Results 151 to 160 of about 60,311 (178)
Some of the next articles are maybe not open access.

Mutation in MERS-CoV

The Middle East respiratory syndrome (MERS-CoV) is a betacoronavirusborne acute viral illness. Since it first appeared in 2012, multiple cases of animal-t- -human transmission of MERS-CoV have been observed, indicating that MERS-CoV has the potential to cause a widespread epidemic.
Faisal Siddique   +7 more
openaire   +1 more source

MERS-CoV: an emerging disease

Independent Nurse, 2014
The latest infectious disease to emerge is Middle East respiratory syndrome, explains Carolyn Driver
openaire   +1 more source

Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection

Proceedings of the National Academy of Sciences of the United States of America, 2020
Jacqueline Cronin   +2 more
exaly  

SARS-CoV, MERS-CoV and SARS-CoV-2: A Diagnostic Challenge

Measurement: Journal of the International Measurement Confederation, 2021
Noel Nesakumar   +2 more
exaly  

MERS-COV VACCINE

2021
KANG CHIL-YONG   +3 more
openaire   +2 more sources

[MERS-CoV: A current review].

Zentralblatt fur Arbeitsmedizin, Arbeitsschutz und Ergonomie
The following article gives a current overview of the newly emerging Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Since first time in summer 2012 in some countries in the Arabian Peninsula there were a number of severe infections of the respiratory tract caused by the new coronavirus.
Matthias, Bundschuh   +1 more
openaire   +1 more source

MERS-COV INHIBITOR PEPTIDES

2021
ELSAYED MAHMOUD KANDEEL   +3 more
openaire   +3 more sources

MERS-CoV spike protein: a key target for antivirals

Expert Opinion on Therapeutic Targets, 2017
Lanying Du, Jiang Shibo, Yang Yang
exaly  

Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4

Cell Research, 2013
Nianshuang Wang   +2 more
exaly  

Home - About - Disclaimer - Privacy